Navigation Links
Vaccine may overcome Common Infections: Researchers

Staphylococcus aureus infections may soon be overcome by a newly developed vaccine according to U.S. researchers on Tuesday.//

The team, receiving funds from the government, said that their vaccine worked against several different strains of the Staphylococcus aureus, in mice. This bacteria causes a range of potentially fatal infections and has become resistant to many antibiotics.

Most hospital-acquired infections are commonly caused by it, causing inflammation of the heart or endocarditis, severe lung infections, toxic-shock syndrome and food poisoning.

In US hospitals around 90,000 people die each year from hospital acquired infections costing about $4.5 billion, according to the U.S. Centers for Disease Control and Prevention. 80 percent of these hospital infections are caused by Staph aureus.

With most strains having developed resistance to antibiotics, these infections are often difficult and sometimes even impossible to treat.

Dr. Olaf Schneewind of the University of Chicago, who led the study, said, "One by one, this organism has learned how to evade nearly all of our current antibiotics. So, generating protective immunity against invasive S. aureus has become an important goal."

According to the CDC in 1972, only 2 percent of Staphylococcus aureus bacteria infections were drug-resistant but in 2004, 63 percent were.

Schneewind's team has created a vaccine that combines four of the proteins that make up Staphylococcus aureus.

Reporting their findings in the Proceedings of the National Academy of Sciences, the research team said that they tested 19 different proteins found in Staph bacteria, and chose the four that stimulated the most immune response in the mice.

Schneewind said, "When we challenged the immunized mice by exposing them to a human strain of S. aureus, the combination vaccine provided complete protection, whereas the control group developed bacterial abscesse s."

On testing the mice with five different S. aureus strains that infect humans it was found that the vaccine offered significant protection against all strains.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which paid for the study, "This finding represents a promising step toward identifying potential components to combine into a vaccine designed for people at high risk of invasive S. aureus infection."

This kind of approach is known as rational drug design. While most vaccines use a whole virus or bacterium that has been crippled or killed and injected into the body to help stimulate immune system recognition this approach has not worked against Staph aureus.


NLA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management ... radiology marketing programs at the annual Building Better Radiology Marketing Programs conference, ... Hotel in Fort Worth, Texas. Nine awards are given out in five categories. They ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: